Determinants of Successful Methicillin-Resistant Staphylococcus aureus Decolonization

Infect Control Hosp Epidemiol. 2016 Jun;37(6):732-6. doi: 10.1017/ice.2016.34. Epub 2016 Feb 16.

Authors

Elodie von Dach¹, Caroline Landelle¹, Americo Agostinho¹, Thomas Haustein¹, Patrice François², Gesuele Renzi³, Jacques Schrenzel⁴, Stephan Harbarth¹

Affiliations

¹ 1Infection Control Program,Geneva University Hospitalsand Faculty of Medicine,Geneva,Switzerland.
² 2Division of Infectious Diseases,Geneva University Hospitalsand Faculty of Medicine,Geneva,Switzerland.
³ 4Clinical Microbiology Laboratory,Geneva University Hospitalsand Faculty of Medicine,Geneva,Switzerland.
⁴ 3Genomic Research Laboratory,Geneva University Hospitalsand Faculty of Medicine,Geneva,Switzerland.

PMID: 26880575
DOI: 10.1017/ice.2016.34

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Anti-Infective Agents, Local / administration & dosage*
Biguanides / administration & dosage*
Carrier State / drug therapy*
Carrier State / microbiology
Drug Resistance, Bacterial
Female
Humans
Male
Methicillin-Resistant Staphylococcus aureus / drug effects
Methicillin-Resistant Staphylococcus aureus / isolation & purification*
Middle Aged
Staphylococcal Infections / drug therapy*
Treatment Outcome

Substances

Anti-Infective Agents, Local
Biguanides
polihexanide